Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “diagnosability”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 451 records · Page 25

Diagnosing Ghost Bunches with the Upstream Extinction Monitor in the Mu2e Experiment

The Mu2e experiment has a stringent requirement for extinction of the pulsed proton beam, referring to the elimination of particles between proton bunches to a relative level of 10$^-10$, which means a single out-of-time particle in the inter-pulse gaps for every 250 complete proton pulses. As the construction of the Mu2e experiment nears completion, it is crucially important to make an early measurement of the beam extinction in its current condition. Hence the upstream extinction monitor was constructed and operated to probe for problems in the proton pulse structure or a higher than expected incidence rate of out-of-time particles. The analysis in this work comes from data taken in March 2026. The long data run showed a significant presence of out-of-time particles from ghost bunches in the Delivery Ring approximately 388 ns after the centers of the main proton pulses. These are hypothesized to be the result of a combination of a RF frequency mismatch, particle space charge, and machine impedance during the rebunching sequence in the Recycler Ring, which can lead to particles leaking into adjacent buckets, but further studies and simulations are needed to confirm this

Hensley, R. [UC, Davis] (ORCID:0000000216064485)↗

Method and device for diagnosing and controlling combustion instabilities in internal combustion engines operating in or transitioning to homogeneous charge combustion ignition mode

This invention is a method of achieving stable, optimal mixtures of HCCI and SI in practical gasoline internal combustion engines comprising the steps of: characterizing the combustion process based on combustion process measurements, determining the ratio of conventional and HCCI combustion, determining the trajectory (sequence) of states for consecutive combustion processes, and determining subsequent combustion process modifications using said information to steer the engine combustion toward desired behavior.

42 ENGINEERING↗

Methods and compositions for diagnosing and preventing a group B streptococcal infection

The present invention provides a group B streptococcal (GBS) surface antigen, designated epsilon antigen, that is co-expressed with the delta antigen on a subset of serotype III GBS. Epsilon is expressed on more pathogenic Restriction Digest Pattern (RDP) III-3 GBS, but not on RDP types 1, 2, or 4. Accordingly, the present invention provides compositions and methods for detecting a group B streptococcus serotype III, RDP III-3 strain. Vaccines and methods of identifying agents which inhibit adhesion of a group B streptococcal cell to a host cell are also provided.

60 APPLIED LIFE SCIENCES↗

Diagnosing implosion velocity and ablator dynamics at NIF (u)

An enhanced understanding of the unique physics probed in a burning NIP capsule is important for both nuclear weapons physics and thermonuclear ignition. In this talk we introduce a new diagnostic idea, designed to measure dynamic aspects of the capsule implosion that are not currently accessible. The current set of diagnostics for the NIF experiments includes reaction history (a time resolved measure of the d + t burn), neutron time-of-flight and spectrometry and spatial imaging of the neutron production and scattering. Although valuable, this abbreviated set of diagnostics cannot determine key dynamical properties of the implosion, such as implosion velocity (v{sub impl}) and ablator thickness. To surpass the present limits of {approx} 10{sup 15} d+t reactions, it will be necessary to increase significantly the implosion energy delivered to the DT fuel by finely tuning the balance between the remaining (imploding) ablator mass and velocity. If too much mass remains, the implosion velocity will be too slow, and the subsecpwnt PdV work will not be sufficient to overcome cooling via conduction and radiation. If too little mass remains, hydrodynamic instabilities will occur, resulting in unpredictable and degraded performance. Detailed calculations suggest the ablator must reach an implosion velocity of 3-4 x 10{sup 7} cm/sec and an areal density of {rho}{Delta}R {approx}200 mg/cm{sup 2} in order to achieve ignition. The authors present a new scheme to measure these important quantities using neutron reactions on the ablator material. During the burn, the ablator is moving relative to the 14.1 MeV d+t neutrons that are traversing the capsule. The resulting neutron-ablator Doppler shift causes a few unique nuclear reactions to become sensitive detectors of the ablator velocity at peak burn time. The 'point-design' capsule at the NIF will be based on a {sup 9}Be ablator, and the {sup 9}Be(n,p){sup 9}Li reaction has an energy threshold of 14.2 MeV, making it the ideal probe. As discussed in detail below, differences in the ablalor velocity lead to significant differences in the rate of {sup 9}Li production. We present techniques for measuring this {sup 9}Li implosion velocity diagnostic at the NIF . The same experimental techniques measuring neutron reactions on the ablator material, will allow us to determine other important dynamical quantities, such as the areal density ({rho}{Delta}R) and approximate thickness ({Delta}R) of the ablator at peak burn.

70 PLASMA PHYSICS AND FUSION TECHNOLOGY↗

Positron Emission Tomography/Computed Tomography in the Staging and Treatment of Anal Cancer

Purpose: This study was intended to determine the role of PET/CT in the staging of anal cancer as a supplement to three-dimensional transanal ultrasound (TAUS) and inguinal ultrasound (US). The impact of the PET/CT on the initial stage and treatment plan proposed by TAUS/US was assessed. Methods and Materials: Ninety-five (95) patients referred to our clinic between July 1, 2005, and December 31, 2009, were retrospectively reviewed. All patients had biopsy-proven primary squamous cell cancer of the anal canal. There were 65 females (68%) and 30 males (32%), and the median age was 58 years (range, 35-88 years). Six (6%) of the patients were HIV positive. All patients were staged with TAUS/US and PET/CT. Results: Twenty-eight (28) patients were diagnosed with suspicious perirectal node metastases. TAUS visualized 24 of these, whereas PET/CT detected 15. Suspicious inguinal nodes were visualized on either US or PET/CT in 41 patients. Seventeen (17) of these had confirmed malignant disease on biopsy, and 15 had confirmed benign disease. All 17 patients (100%) with malignant inguinal nodes were diagnosed by PET/CT, whereas US identified 16 (94%). Ten patients were diagnosed with suspicious inguinal nodes on PET/CT that had not been seen on US. One of these was malignant, three were benign, and six were not biopsied. PET/CT diagnosed eight metastatic sites, whereas TAUS/US diagnosed three. PET/CT discovered three of the five synchronous cancers seen in this study. PET/CT upstaged the disease in 14% of the cases and changed the treatment plan proposed by TAUS/US in 17%. Conclusion: PET/CT has great potential influence on the staging and treatment of anal cancer. TAUS is important in the staging of the primary tumor and N1-stage, whereas PET/CT seems necessary for the N2/3-stage, the M-stage and synchronous cancers.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Improving five-year survival prediction via multitask learning across HPV-related cancers

Oncology is a highly siloed field of research in which sub-disciplinary specialization has limited the amount of information shared between researchers of distinct cancer types. This can be attributed to legitimate differences in the physiology and carcinogenesis of cancers affecting distinct anatomical sites. However, underlying processes that are shared across seemingly disparate cancers probably affect prognosis. The objective of the current study is to investigate whether multitask learning improves 5-year survival cancer patient survival prediction by leveraging information across anatomically distinct HPV related cancers. Furthermore, data were obtained from the Surveillance, Epidemiology, and End Results (SEER) program database. The study cohort consisted of 29,768 primary cancer cases diagnosed in the United States between 2004 and 2015. Ten different cancer diagnoses were selected, all with a known association with HPV risk. In the analysis, the cancer diagnoses were categorized into three distinct topography groups of varying specificity. The most specific topography grouping consisted of 10 original cancer diagnoses differentiated by the first two digits of the ICD-O-3 topography code. The second topography grouping consisted of cancer diagnoses categorized into six distinct organ groups. Finally, the third topography grouping consisted of just two groups, head-neck cancers and ano-genital cancers. The tasks were to predict 5-year survival for patients within the different topography groups using 14 predictive features which were selected among descriptive variables available in the SEER database. The information from the predictive features was shared between tasks in three different ways, resulting in three distinct predictive models: 1) Information was not shared between patients assigned to different tasks (single task learning); 2) Information was shared between all patients, regardless of task (pooled model); 3) Only relevant information was shared between patients grouped to different tasks (multitask learning). Prediction performance was evaluated with Brier scores. All three models were evaluated against one another on each of the three distinct topography-defined tasks. The results showed that multitask classifiers achieved relative improvement for the majority of the scenarios studied compared to single task learning and pooled baseline methods. In this study, we have demonstrated that sharing information among anatomically distinct cancer types can lead to improved predictive survival models.

59 BASIC BIOLOGICAL SCIENCES↗

Improving Distributed Diagnosis Through Structural Model Decomposition

Complex engineering systems require efficient fault diagnosis methodologies, but centralized approaches do not scale well, and this motivates the development of distributed solutions. This work presents an event-based approach for distributed diagnosis of abrupt parametric faults in continuous systems, by using the structural model decomposition capabilities provided by Possible Conflicts. We develop a distributed diagnosis algorithm that uses residuals computed by extending Possible Conflicts to build local event-based diagnosers based on global diagnosability analysis. The proposed approach is applied to a multitank system, and results demonstrate an improvement in the design of local diagnosers. Since local diagnosers use only a subset of the residuals, and use subsystem models to compute residuals (instead of the global system model), the local diagnosers are more efficient than previously developed distributed approaches.

Bregon, Anibal↗

Effects of Mesoscale Eddies in the Active Mixed Layer: Test of the Parametrisation in Eddy Resolving Simulations

In eddy resolving simulations, we test a mixed layer mesoscale parametrisation, developed recently by Canuto and Dubovikov [Ocean Model., 2011, 39, 200-207]. With no adjustable parameters, the parametrisation yields the horizontal and vertical mesoscale fluxes in terms of coarse-resolution fields and eddy kinetic energy (EKE). We compare terms of the parametrisation diagnosed from coarse-grained fields with the eddy mesoscale fluxes diagnosed directly from the high resolution model. An expression for the EKE in terms of mean fields has also been found to get a closed parametrisation in terms of the mean fields only. In 40 numerical experiments we simulated two types of flows: idealised flows driven by baroclinic instabilities only, and more realistic flows, driven by wind and surface fluxes as well as by inflow-outflow. The diagnosed quasi-instantaneous horizontal and vertical mesoscale buoyancy fluxes (averaged over 1-2 degrees and 10 days) demonstrate a strong scatter typical for turbulent flows, however, the fluxes are positively correlated with the parametrisation with higher (0.5-0.74) correlations at the experiments with larger baroclinic radius Rossby. After being averaged over 3-4 months, diffusivities diagnosed from the eddy resolving simulations are consistent with the parametrisation for a broad range of parameters. Diagnosed vertical mesoscale fluxes restratify mixed layer and are in a good agreement with the parametrisation unless vertical turbulent mixing in the upper layer becomes strong enough in comparison with mesoscale advection. In the latter case, numerical simulations demonstrate that the deviation of the fluxes from the parametrisation is controlled by dimensionless parameter estimating the ratio of vertical turbulent mixing term to mesoscale advection. An analysis using a modified omega-equation reveals that the effects of the vertical mixing of vorticity is responsible for the two-three fold amplification of vertical mesoscale flux. Possible physical mechanisms, responsible for the amplification of vertical mesoscale flux are discussed.

simulation↗

Evaluation of the Role of Radiation Therapy in the Management of Malignant Thymoma

Purpose: The management of patients diagnosed with thymoma remains unclear. This report attempts to identify the impact of adjuvant radiotherapy on overall survival (OS) and cause-specific survival (CSS) in patients diagnosed with thymoma. Methods and Materials: Patients diagnosed with thymic malignancy between 1973 and 2003 were retrospectively identified from centers participating in the Surveillance, Epidemiology, and End Results (SEER) program. Those patients classified as having thymic carcinoma were excluded from this analysis. OS and CSS were estimated by the Kaplan-Meier method. Outcomes for patients treated with and without radiation therapy were compared using the log-rank test. Multivariate analysis was performed with the Cox proportional hazards model to analyze factors predictive of OS and CSS. Results: A total of 1,464 patients were identified as having thymic malignancy, and of these, 1,254 patients were identified as having malignant thymoma. The median follow-up time was 41 months (range, 4-337 months). Among patients who did not receive radiotherapy (RT), the 10-year rate of OS was 41% compared to 42% for those who did receive RT (p = 0.06). The median OS for the patients who did not receive RT was 80 months compared to 97 months for those who did receive RT. In patients with Masaoka stage II-III malignancy, OS was significantly improved with RT (p = 0.002), and a trend in improved CSS was observed (p = 0.1). Patients were also analyzed based on resection status. For those patients who had an incomplete excision, the 10-year OS was 63% with RT and 46% without RT (p = 0.38). On multivariate analysis, factors predictive of OS included age, extent of surgery, stage, and number of lymph nodes examined. Conclusions: This study reports treatment results of a large cohort of patients who were diagnosed with malignant thymoma. This study demonstrates that the use of RT following resection for thymoma significantly improves OS for those with regional disease and marginally improves CSS.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer

Purpose: It has been recently shown that diabetes mellitus (DM) is significantly associated with the likelihood of presenting with high-grade prostate cancer (PCa) or Gleason score (GS) 8 to 10; however, whether this association holds for both Type 1 and 2 DM is unknown. In this study we evaluated whether DM Type 1, 2, or both are associated with high-grade PCa after adjusting for known predictors of high-grade disease. Methods and Materials: Between 1991 and 2010, a total of 15,330 men diagnosed with PCa and treated with radiation therapy were analyzed. A polychotomous logistic regression analysis was performed to evaluate whether Type 1 or 2 DM was associated with odds of GS 7 or GS 8 to 10 compared with 6 or lower PCa, adjusting for African American race, age, prostate-specific antigen (PSA) level, and digital rectal examination findings. Results: Men with Type 1 DM (adjusted odds ratio [AOR], 2.05; 95% confidence interval [CI], 1.28-3.27; p = 0.003) or Type 2 DM (AOR, 1.58; 95% CI, 1.26-1.99; p < 0.001) were significantly more likely to be diagnosed with GS 8 to 10 PCa compared with nondiabetic men. However this was not true for GS 7, for which these respective results were AOR, 1.30; 95% CI, 0.93-1.82; p = 0.12 and AOR, 1.13; 95% CI, 0.98-1.32; p = 0.10. Conclusion: Type 1 and 2 DM were associated with a higher odds of being diagnosed with Gleason score 8 to 10 but not 7 PCa. Pending validation, men who are diagnosed with Type I DM with GS 7 or lower should be considered for additional workup to rule out occult high-grade disease.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach

Purpose: Palliative radiation therapy (PRT) benefits many patients with incurable cancer, but the overall need for PRT is unknown. Our primary objective was to estimate the appropriate rate of use of PRT in Ontario. Methods and Materials: The Ontario Cancer Registry identified patients who died of cancer in Ontario between 2006 and 2010. Comprehensive RT records were linked to the registry. Multivariate analysis identified social and health system-related factors affecting the use of PRT, enabling us to define a benchmark population of patients with unimpeded access to PRT. The proportion of cases treated at any time (PRT{sub lifetime}), the proportion of cases treated in the last 2 years of life (PRT{sub 2y}), and number of courses of PRT per thousand cancer deaths were measured in the benchmark population. These benchmarks were standardized to the characteristics of the overall population, and province-wide PRT rates were then compared to benchmarks. Results: Cases diagnosed at hospitals with no RT on-site and residents of poorer communities and those who lived farther from an RT center, were significantly less likely than others to receive PRT. However, availability of RT at the diagnosing hospital was the dominant factor. Neither socioeconomic status nor distance from home to nearest RT center had a significant effect on the use of PRT in patients diagnosed at a hospital with RT facilities. The benchmark population therefore consisted of patients diagnosed at a hospital with RT facilities. The standardized benchmark for PRT{sub lifetime} was 33.9%, and the corresponding province-wide rate was 28.5%. The standardized benchmark for PRT{sub 2y} was 32.4%, and the corresponding province-wide rate was 27.0%. The standardized benchmark for the number of courses of PRT per thousand cancer deaths was 652, and the corresponding province-wide rate was 542. Conclusions: Approximately one-third of patients who die of cancer in Ontario need PRT, but many of them are never treated.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Association of post-COVID phenotypic manifestations with new-onset psychiatric disease

Acute COVID-19 infection can be followed by diverse clinical manifestations referred to as Post Acute Sequelae of SARS-CoV2 Infection (PASC). Studies have shown an increased risk of being diagnosed with new-onset psychiatric disease following a diagnosis of acute COVID-19. However, it was unclear whether non-psychiatric PASC-associated manifestations (PASC-AMs) are associated with an increased risk of new-onset psychiatric disease following COVID-19. A retrospective electronic health record (EHR) cohort study of 2,391,006 individuals with acute COVID-19 was performed to evaluate whether non-psychiatric PASC-AMs are associated with new-onset psychiatric disease. Data were obtained from the National COVID Cohort Collaborative (N3C), which has EHR data from 76 clinical organizations. EHR codes were mapped to 151 non-psychiatric PASC-AMs recorded 28–120 days following SARS-CoV-2 diagnosis and before diagnosis of new-onset psychiatric disease. Association of newly diagnosed psychiatric disease with age, sex, race, pre-existing comorbidities, and PASC-AMs in seven categories was assessed by logistic regression. There were significant associations between a diagnosis of any psychiatric disease and five categories of PASC-AMs with odds ratios highest for neurological, cardiovascular, and constitutional PASC-AMs with odds ratios of 1.31, 1.29, and 1.23 respectively. Secondary analysis revealed that the proportions of 50 individual clinical features significantly differed between patients diagnosed with different psychiatric diseases. Our study provides evidence for association between non-psychiatric PASC-AMs and the incidence of newly diagnosed psychiatric disease. Significant associations were found for features related to multiple organ systems. This information could prove useful in understanding risk stratification for new-onset psychiatric disease following COVID-19. Prospective studies are needed to corroborate these findings.

60 APPLIED LIFE SCIENCES↗

Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease

Background. Despite extensive medical evaluation many patients with chronic disease remain without a diagnosis. The Undiagnosed Diseases Network (UDN) was established to embrace the most challenging cases in medicine and to characterize the biology of newly discovered diseases. Methods. The UDN was formed in 2014 as a National Institutes of Health (NIH)-funded network of seven clinical sites, two sequencing cores, and a coordinating center. Later a central biorepository, metabolomics core, and model organisms screening center were added. We undertook a retrospective evaluation of the patients referred since the network formed to evaluate the efficacy of this approach. Results. Between September 16, 2015 and May 23, 2017, 1519 patients were referred to the network (53% female). Six hundred and one cases (40%) were accepted for evaluation (53% female). Of those accepted, 192 (32%) had previously undergone exome sequencing. The most common primary symptom categories of accepted patients were neurological (40%), musculoskeletal (9.7%), immunological (6.8%), gastrointestinal (6.5%), and rheumatological (5.7%). The number of completed evaluations on May 23, 2017, was 365, at which time, 100 patients had received diagnoses. In the intervening period, a further 25 received a diagnosis indicating a network diagnosis rate of 34%. Some diagnoses were made from clinical review alone (10%). Many were informed through sequencing the exomes or genomes of the patient or family (72%). A majority of diagnoses (83%) were deemed medically actionable by the clinical team. Indeed, of the total, 30% led to changes in therapy, 24% led to changes in the diagnostic workup, and 28% allowed variant-specific genetic counseling. Through the combined work of the network, a total of 24 new syndromes were defined. Conclusions. A collaborative network with access to state-of-the-art diagnostic tools can expand the medical record of human disease providing actionable clinical diagnoses to a substantial majority of those patients.

Splinter, Kimberly↗

Demonstration of x-ray fluorescence imaging of a high-energy-density plasma

Experiments at the Trident Laser Facility have successfully demonstrated the use of x-ray fluorescence imaging (XRFI) to diagnose shocked carbonized resorcinol formaldehyde (CRF) foams doped with Ti. One laser beam created a shock wave in the doped foam. A second laser beam produced a flux of vanadium He-α x-rays, which in turn induced Ti K-shell fluorescence within the foam. Spectrally resolved 1D imaging of the x-ray fluorescence provided shock location and compression measurements. Additionally, experiments using a collimator demonstrated that one can probe specific regions within a target. These results show that XRFI is a capable alternative to path-integrated measurements for diagnosing hydrodynamic experiments at high energy density.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

L-shell spectroscopic diagnostics of radiation from krypton HED plasma sources

X-ray spectroscopy is a useful tool for diagnosing plasma sources due to its non-invasive nature. One such source is the dense plasma focus (DPF). Recent interest has developed to demonstrate its potential application as a soft x-ray source. We present the first spectroscopic studies of krypton high energy density plasmas produced on a 3 kJ DPF device in Singapore. In order to diagnose spectral features, and to obtain a more comprehensive understanding of plasma parameters, a new non-local thermodynamic equilibrium L-shell kinetic model for krypton was developed. It has the capability of incorporating hot electrons, with different electron distribution functions, in order to examine the effects that they have on emission spectra. To further substantiate the validity of this model, it is also benchmarked with data gathered from experiments on the electron beam ion trap (EBIT) at Lawrence Livermore National Laboratory, where data were collected using the high resolution EBIT calorimeter spectrometer.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗